Form 4: Atlassian CEO Michael Cannon-Brookes Sells Shares Under 10b5-1 Trading Plan
SEC Form 4 Filing
Atlassian CEO Michael Cannon-Brookes executed multiple sales of Class A Common Stock on April 24, 2025, under a pre-arranged Rule 10b5-1 trading plan.
Summary
- Michael Cannon-Brookes, CEO and Co-Founder of Atlassian, reported the sale of Class A Common Stock on April 24, 2025.
- The sales were executed under a Rule 10b5-1 trading plan adopted on February 8, 2024.
- Multiple transactions occurred at varying prices throughout the day, with weighted-average prices ranging from $216.3575 to $225.7693.
- The shares were sold both directly and indirectly through a trust (CBC Co Pty Limited as trustee for the Cannon-Brookes Head Trust).
- Following the reported transactions, the number of shares held indirectly by the trust decreased.
Sentiment
Score: 5
Explanation: The document is a standard SEC Form 4 filing, indicating insider trading activity. The sentiment is neutral as it simply reports transactions executed under a pre-arranged plan.
Industry Context
Insider selling is a common occurrence, and the use of 10b5-1 plans allows insiders to sell shares over time while avoiding accusations of trading on non-public information. The market typically analyzes the size and frequency of such sales to gauge potential impact.
Stakeholder Impact
- Shareholders may react to the news of insider selling, although the existence of a 10b5-1 plan mitigates concerns about opportunistic trading.
Key Dates
| Date | Description |
|---|---|
| 02/08/2024 | Date the Reporting Person adopted the Rule 10b5-1 trading plan |
| 04/24/2025 | Date of the reported transactions (sale of Class A Common Stock) |
| 04/25/2025 | Date of the Form 4 filing |
Keywords
Atlassian, Michael Cannon-Brookes, TEAM, Class A Common Stock, SEC Form 4, Rule 10b5-1, Insider Trading, CBC Co Pty Limited, Cannon-Brookes Head Trust, Share Sale
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.